Mylan Announces Global Settlement and License Agreements with Genentech and Roche on Herceptin(R)

HERTFORDSHIRE, England and PITTSBURGH, March 13, 2017 -- (Healthcare Sales & Marketing Network) -- Mylan N.V. (NASDAQ, TASE: MYL) today announced that Mylan has agreed to the terms of a global settlement with Genentech, Inc. and F. Hoffmann-La Roche Ltd. ... Biopharmaceuticals, Oncology, Generics, Licensing Mylan, Genentech, Roche Group, Herceptin, trastuzumab, breast cancer
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news